AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
FDA is cracking down on unapproved Rx drugs.(Practice Trends)
The Food and Drug Administration announced that it is renewing efforts to ensure that all drugs currently sold by prescription either go through its formal approval process or be taken off the market.
The agency has periodically targeted some of these products using its existing authority. Now, the FDA has issued more formal guidance that spells out for manufacturers how it will prioritize enforcement, and what route they can take to prove safety and efficacy of their products.
There are many reasons why unapproved products are on the market, said Dr. Steven Galson, director of the FDA's Center for Drug Evaluation and Research, at a press briefing sponsored by the agency.
Most were marketed before passage of the 1962 Food, Drug, and Cosmetic Act, which required formal proof of safety and efficacy. Or their makers may simply have begun selling the products without seeking the agency's approval, he said, noting that the FDA will issue a new drug code number for a product even if it was never approved.
Many of the unapproved drugs are listed in the Physicians' Desk Reference. Some are advertised in medical journals. Those initially flagged for attention include products that are potentially hazardous, lack evidence of effectiveness, or appear fraudulent. If the manufacturers don't seek approval, they will be subject to enforcement action, Dr. Galson said. But in most cases, the FDA will not ...
- FDA to sharpen postmarketing drug safety focus.(Practice Trends)
- Magazine article from: Internal Medicine News Ault, Alicia March 1, 2007 700+ words
...introduce a bill to further overhaul FDA's postmarketing safety program...Center would report directly to the FDA commissioner. "Congress will act on FDA-related legislation this year...BY ALICIA AULT Associate Editor, Practice Trends
- Report faults FDA for lack of postmarketing focus.(Practice Trends)
- Magazine article from: Internal Medicine News Ault, Alicia November 1, 2006 700+ words
...postmarketing safety efforts. "The FDA has led an aggressive effort...drug safety issues," acting FDA Commissioner Andrew von Eschenbach...Manufacturers of America also defended FDA's recent strides and the industry...ALICIA AULT Associate Editor, Practice Trends
- FDA seeks to increase fees for drug makers.(Practice Trends)(food and drug...
- Magazine article from: Internal Medicine News Ault, Alicia February 1, 2007 700+ words
...of America, in a statement. FDA is proposing to create a new...submit ads for review, but the FDA has not been able to keep up...workload, Dr. Galson said. The FDA anticipates charging $6 million...ALICIA AULT Associate Editor, Practice Trends
- FDA's new drug safety board under scrutiny.(Practice Trends)
- Magazine article from: OB GYN News Silverman, Jennifer March 1, 2005 700+ words
...deflect recent criticisms that FDA hasn't been meeting its charge...safety agency. In particular, FDA has been criticized for not...2004. In PhRMA's view, the FDA has already responded "quickly...SILVERMAN Associate Editor, Practice Trends
- FDA seeks $87 million more in fees from drug manufacturers.(Practice Trends)
- Magazine article from: Pediatric News Ault, Alicia February 1, 2007 700+ words
...their ads for review, but the FDA has not been able to keep up...workload, said Dr. Galson. The FDA anticipates charging $6 million...lauded the new program. "The FDA would have more resources to...ALICIA AULT Associate Editor, Practice Trends
- FDA demands approval data on carbinoxamine.(Practice Trends)
- Magazine article from: Pediatric News Ault, Alicia July 1, 2006 700+ words
...more suitable, according to the FDA. Physicians, patients, and pharmacists can continue to check the FDA's Web site (www.accessdata.fda.gov/scripts/cder/ drugsatfda...BY ALICIA AULT Associate Editor, Practice Trends
- FDA to sharpen focus on postmarketing drug safety.(Practice Trends)
- Magazine article from: Family Practice News Ault, Alicia February 15, 2007 700+ words
...introduce a bill to further overhaul the FDA's postmarketing safety program...center would report directly to the FDA commissioner. "Congress will act on FDA-related legislation this year...BY ALICIA AULT Associate Editor, Practice Trends
- More postmarketing data to be gathered by FDA.(Practice Trends)(Food and Drug...
- Magazine article from: Internal Medicine News Ault, Alicia May 1, 2007 700+ words
...terrified of FDA." Mr. Hutt said FDA had all the enforcement power...the user fees it collects. FDA critics have said the agency...because of user fees. Former FDA Deputy Commissioner Mary Pendergast...ALICIA AULT Associate Editor, Practice Trends
- Congress weighs giving FDA more authority.(Practice Trends)
- Magazine article from: OB GYN News Frieden, Joyce April 15, 2005 700+ words
...on consumer attitudes toward the FDA. The survey of 1,000 adults nationwide...48% of respondents believed the FDA was too influenced by the industries...whose results had been submitted to FDA." BY JOYCE FRIEDEN Associate Editor, Practice Trends
- FDA cracking down on unapproved prescription drugs.(Practice Trends)(Food and...
- Magazine article from: Internal Medicine News Ault, Alicia August 15, 2006 700+ words
...market, said Deborah M. Autor, FDA associate director for compliance...pharmacists, and patients can go to the FDA's Web site (www.accessdata.fda.gov/scripts/cder/drugsatfda...BY ALICIA AULT Associate Editor, Practice Trends
Source: HighBeam Research, FDA is cracking down on unapproved Rx drugs.(Practice Trends)